• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    RH filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    6/12/25 4:19:55 PM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary
    Get the next $RH alert in real time by email
    RH_June 12, 2025
    RH0001528849false00015288492025-06-122025-06-12

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    ​

    FORM 8-K

    ​

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): June 12, 2025

    ​

    Graphic

    (Exact name of registrant as specified in its charter)

    ​

    ​

    Delaware

     

    001-35720

     

    45-3052669

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

    ​

    15 Koch Road, Corte Madera, California 94925

    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code: (415) 924-1005

    N/A

    (Former name or former address, if changed since last report.)

    ​

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    ​

    ​

    ​

    ​

    ​

    Title of each class

    ​

    Trading symbol

    ​

    Name of each exchange on which registered

    Common Stock, $0.0001 par value

    ​

    RH

    ​

    New York Stock Exchange

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    ​

    Emerging growth company ☐

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    ​

    Item 2.02. Results of Operations and Financial Condition.

    On June 12, 2025, RH released its financial results for the first quarter ended May 3, 2025 in a letter to shareholders that is available on the investor relations section of its website. Copies of the press release announcing the release of financial results and the letter to shareholders are attached hereto as Exhibits 99.1 and 99.2, respectively, and are incorporated herein by reference.

    The information provided in this Item 2.02, including Exhibits 99.1 and 99.2, is intended to be “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

    RH is also disclosing that it may use the rh.com, restorationhardware.com, and ir.rh.com websites as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

    Item 9.01. Financial Statements and Exhibits.

    (d)

    Exhibits.

    ​

    Exhibit
    No.

      

    Description

    99.1

      

    Press Release dated June 12, 2025 announcing the release of first quarter 2025 results.

    ​

    ​

    ​

    99.2

      

    RH first quarter 2025 financial results and shareholder letter dated June 12, 2025.

    ​

    ​

    ​

    104

    ​

    Cover Page Interactive Data File––the cover page XBRL tags are embedded within the Inline XBRL document.

    ​

    ​

    ​

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

    Graphic

    ​

    ​

    Dated: June 12, 2025

    By: 

    /s/ Jack Preston

     

    Jack Preston

     

    Chief Financial Officer

    ​

    ​

    ​

    Get the next $RH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RH

    DatePrice TargetRatingAnalyst
    6/9/2025$280.00 → $255.00Outperform
    Telsey Advisory Group
    4/3/2025$410.00 → $130.00Buy → Underperform
    BofA Securities
    4/3/2025$200.00Buy → Neutral
    Citigroup
    4/3/2025$420.00 → $280.00Outperform
    Telsey Advisory Group
    3/24/2025$500.00 → $420.00Outperform
    Telsey Advisory Group
    1/30/2025$261.00 → $374.00Sell → Neutral
    Goldman
    1/13/2025$435.00 → $530.00Equal-Weight → Overweight
    Morgan Stanley
    1/8/2025$383.00 → $515.00Equal Weight → Overweight
    Barclays
    More analyst ratings